RARhoGAP/ARHGAP20) and pancreas (PA/AMY2B and APC2) were used as the starting point for algorithmically generating the respective biological networks based on their connectivity as established in the published literature. Restricting species to 'rat', tissue to 'liver' or 'pancreas', disease to 'metabolic disease', and allowing for findings to experimentally observed/highly predicted confidence levels, direct/indirect interactions, and exclusion of chemicals and drugs, interactions were added using the IPA Path Explorer application. Given the specified criteria, this application was used to: (i) add a number of extra molecules or relationships from the knowledge database, and (ii) find among the Ingenuity Knowledge Base and external databases for the shortest paths connecting the selected nodes through one or two IPA-derived intermediate molecules to explore putative biologic interactions. For example, SPARC was selected to node-A and BHMT was selected to node-B to generate biological interactions between SPARC and BHMT, and rest of the interactions were predicted for all probable combinations of SPARC (mapped always as central node) and its interacting proteins. The shortest paths by which SPARC and its interacting proteins were integrated required minimum one or two interconnecting nodes. Proteins or nodes with no color were undetected in the study but have been incorporated by IPA to produce a highly connected network. In addition, we subjected the molecular networks that were built by Ingenuity to functional analysis using the Overlay tool. As a result, IPA assigns bio-functional categories/cellular functions (along with statistical evidence) to the respective molecular networks, indicating the p-value ranges, and the molecules involved for each category. p-Value referred to a right-tailed Fisher's exact tests calculating that the set of proteins were associated with a specific disease/function by chance alone.
